Survey analysis of the psychological aspects of living with IPF: 33 patients from 6 different countries. Results presented at the 2021 Pulmonary Fibrosis Foundation Summit. The poster session was presented by Jessica Shull, Director of Digital Therapeutics at Vicore Pharma.
Patient insights to shape development of a dCBT for IPF patients
Read more posts
Science
Related posts
Interview with Ella Radvogin, Clinical Psychologist at Alex Therapeutics
Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic
Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients
C21 shows promise against COVID-19 where other drugs have failed
MedNous article: A surprise finding in the clinic